Gilead Sciences, Inc. (BVMF:GILD34)
350.17
+3.17 (0.91%)
At close: Dec 23, 2025
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of 860.75 billion as of December 24, 2025. Its market cap has increased by 25.71% in one year.
Market Cap
860.75B
Enterprise Value
940.04B
Revenue
155.02B
Ranking
n/a
PE Ratio
19.91
Stock Price
350.17
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 240.84M to 860.75B, an increase of 357,295.58%. That is a compound annual growth rate of 27.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 860.75B | 20.89% |
| Dec 31, 2024 | 711.99B | 45.36% |
| Dec 29, 2023 | 489.80B | -13.96% |
| Dec 30, 2022 | 569.24B | 12.17% |
| Dec 31, 2021 | 507.47B | 33.81% |
| Dec 31, 2020 | 379.26B | 14.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 89.22B |
| Raia Drogasil | 39.93B |
| Hypera | 14.67B |
| Fleury | 7.98B |
| Odontoprev | 5.89B |
| Diagnósticos da América | 5.45B |
| Empreendimentos Pague Menos | 3.89B |
| Oncoclínicas do Brasil Serviços Médicos | 3.22B |